Suzano Joins in Dow Jones Sustainability Index

Suzano Joins in Dow Jones Sustainability Index

Selection considers only the best companies in each sector assessed globally

SÃO PAULO–(BUSINESS WIRE)–Suzano, a global reference in the manufacture of bioproducts developed from the cultivation of eucalyptus, has been selected to join the notable 2020-2021 portfolio of the Dow Jones Sustainability Emerging Markets Index (DJSI Emerging Markets). The index is composed of only 10% of the best companies in each sector, from among the 780 biggest companies assessed from the 20 countries characterized as emerging markets.

Apart from Suzano, only 10 other Brazilian companies have been included in the new portfolios underlying the DJSI indices, as announced on November 13 by the Swiss assessment company SAM, a member of S&P Global.

The prestigious Dow Jones Sustainability Index was created in 1999 to identify companies with the best sustainability practices by assessing several economic, environmental and social criteria, with the focus on creating long-term value for shareholders. The annual selection process is audited externally by Deloitte.

“We will continue to dedicate ourselves to ensure that our environmental, social and governance practices are continuously recognized facing the dynamic ESG agenda and the growing global focus on long-term value creation in a sustainable manner,” says Marcelo Bacci, CFO and IRO of Suzano.

About Suzano:

Suzano, the company resulting from the merger of Suzano Pulp & Paper and Fibria, is committed to being a global reference in the sustainable use of natural resources. The world’s leading producer of eucalyptus pulp and one of Latin America’s largest paper producers, Suzano exports to more than 80 countries and, through its products, plays a part in the lives of over two billion people. With ten mills and the joint operation Veracel, Suzano has annual installed capacity of 10.9 million tons of market pulp and 1.4 million tons of paper. Suzano has more than 35,000 direct and indirect employees and for over 90 years has invested in innovative solutions based on eucalyptus cultivation that enable it to substitute the use of fossil-based materials with renewable bio-based materials. The company adopts the highest standards of corporate governance on the exchanges where its stock is traded, namely the B3 in Brazil and the NYSE in the United States.

PLANIN – Suzano’s PR Agency

Angélica Consiglio, Beatriz Imenes and team – www.planin.com

E-mail: [email protected] – Phone: +55 (11) 98758-6504

KEYWORDS: South America Brazil

INDUSTRY KEYWORDS: Forest Products Natural Resources Other Manufacturing Manufacturing

MEDIA:

Seneca Centre for Innovation in Life Sciences launches

Applied research facility connects academics and industry, with a focus on diagnostics and cosmetics

Toronto, Nov. 16, 2020 (GLOBE NEWSWIRE) — Seneca has launched the Seneca Centre for Innovation in Life Sciences (SCILS) a first-of-its-kind applied research facility, where students and faculty can connect directly with industry partners to develop, enhance and validate innovations in diagnostics and cosmetics.

The project was made possible through a $2 million Innovation Enhancement grant from the Natural Sciences and Engineering Research Council (NSERC).

“SCILS provides an environment for students, faculty and businesses to collaborate on new technologies and products for the life sciences diagnostics and cosmetic science sectors,” said Ben Rogers, Dean of Seneca Innovation. “Applied research partnerships between industry and academia have always been integral to the regional innovation ecosystem. The impacts of these partnerships become clear when businesses grow and highly-qualified students get a head start in building their careers.”

Research conducted at SCILS will be led by expert faculty from Seneca’s School of Biological Sciences & Applied Chemistry, along with the support of laboratory technicians and student research assistants.

SCILS will focus on life sciences diagnostics, which include metabolomics testing, biochemical diagnostics, immunodiagnostics and molecular diagnostics in both clinical and industrial settings. There will also be a focus on developing new cosmetic products that appropriately meet the scientific regulatory requirements for consumer use and marketing, leveraging expertise from Seneca’s Cosmetic Science program and assisting companies across the country to address this product development challenge.

“Congratulations to Seneca for launching the SCILS program. SCILS will have a positive impact on the diagnostics innovation ecosystem in Ontario as a catalyst to actively bridge the academic and industrial communities toward new discoveries and scientific excellence in the biotechnology sector,” said Ryan Hayman, VP, Research and Development at ChipCare Corp. “ChipCare has partnered with Seneca on several R&D projects in the past few years and we’re really looking forward to kicking off several key projects in the inaugural year of the SCILS program to advance our strategic roadmap.” 

About Seneca

Combining career and professional skills training with theoretical knowledge, Seneca provides a polytechnic education to 30,000 full-time and 60,000 part-time students. With campuses in Toronto, York Region and Peterborough and education partners around the world, Seneca offers degrees, graduate certificates, diplomas and certificates in more than 300 full-time, part-time and online programs, now most of them virtually. Seneca’s credentials are renowned for their quality and respected by employers. Co-op and work placements, applied research projects, entrepreneurial opportunities and the latest technology ensure that Seneca graduates are highly skilled and ready to work.

Find out more about Seneca.

Follow us on Twitter.

About ChipCare

ChipCare Corp., is a Toronto-based company developing a highly versatile point-of-care (POC) diagnostic platform – through which clinicians can rapidly and accurately perform lab quality tests to aid in the diagnosis OR monitoring of a wide range of infectious diseases.



Caroline Grech
Seneca
[email protected]

BMO Global Asset Management Announces Estimated Annual Reinvested Distributions for BMO Exchange Traded Funds and ETF Series

Canada NewsWire

TORONTO, Nov. 16, 2020 /CNW/ – BMO Asset Management Inc. and BMO Investments Inc. today announced the estimated 2020 annual reinvested distributions for BMO Exchange Traded Funds (BMO ETFs) and ETF Series of the BMO Mutual Funds (ETF Series)1. These annual reinvested distributions generally represent realized capital gains and special income within the BMO ETFs and ETF Series, and are paid to unitholders, as required, to ensure that the BMO ETFs and ETF Series are not liable for ordinary income tax.

Unitholders of record at close of business on December 30, 2020 will receive the 2020 annual reinvested distributions. The final year-end distribution amounts, as well as the ongoing cash distribution amounts, are expected to be announced on December 18, 2020. The actual taxable amounts, including the tax characteristics, will be reported in 2021.

Please note that these are estimated annual reinvested distributions only and have been calculated based upon forward-looking information as of October 23, 20202. If the forward-looking information changes, the estimated annual reinvested distributions may also change.

These estimates are for the annual reinvested distributions only and do not include estimates of ongoing cash distribution amounts.

Details of the per-unit estimated annual reinvested distribution amounts are as follows:


BMO ETFs


Ticker


Estimated
Reinvested
Distribution
($)

BMO Aggregate Bond Index ETF

ZAG

0.000

BMO Discount Bond Index ETF

ZDB

0.692

BMO Short-Term Bond Index ETF

ZSB

0.047

BMO Core Plus Bond Fund – ETF Series

ZCPB

0.505

BMO Global Multi-Sector Bond Fund – ETF Series

ZMSB

0.000

BMO Global Strategic Bond Fund – ETF Series

ZGSB

0.000

BMO Ultra Short-Term Bond ETF

ZST

0.000

BMO Ultra Short-Term Bond ETF (Accumulating Units)

ZST.L

1.010

BMO Ultra Short-Term US Bond ETF (USD Units)

ZUS.U

0.000

BMO Ultra Short-Term US Bond ETF (USD Accumulating Units)

ZUS.V

1.145

BMO Government Bond Index ETF

ZGB

0.000

BMO Short Federal Bond Index ETF

ZFS

0.000

BMO Short Federal Bond Index ETF (Accumulating Units)

ZFS.L

0.256

BMO Mid Federal Bond Index ETF

ZFM

0.252

BMO Long Federal Bond Index ETF

ZFL

0.320

BMO Real Return Bond Index ETF

ZRR

0.074

BMO Short Provincial Bond Index ETF

ZPS

0.000

BMO Short Provincial Bond Index ETF (Accumulating Units)

ZPS.L

0.383

BMO Mid Provincial Bond Index ETF

ZMP

0.000

BMO Long Provincial Bond Index ETF

ZPL

0.098

BMO Short-Term US Treasury Bond Index ETF

ZTS

0.004

BMO Short-Term US Treasury Bond Index ETF (USD Units)

ZTS.U

0.230

BMO Mid-Term US Treasury Bond Index ETF

ZTM

0.318

BMO Mid-Term US Treasury Bond Index ETF (USD Units)

ZTM.U

0.339

BMO Long-Term US Treasury Bond Index ETF

ZTL

1.019

BMO Long-Term US Treasury Bond Index ETF (Hedged Units)

ZTL.F

2.196

BMO Long-Term US Treasury Bond Index ETF (USD Units)

ZTL.U

0.764

BMO Canadian MBS Index ETF

ZMBS

0.043

BMO Corporate Bond Index ETF

ZCB

0.000

BMO ESG Corporate Bond Index ETF

ESGB

0.000

BMO High Quality Corporate Bond Index ETF

ZQB

0.000

BMO BBB Corporate Bond Index ETF

ZBBB

0.000

BMO Short Corporate Bond Index ETF

ZCS

0.000

BMO Short Corporate Bond Index ETF (Accumulating Units)

ZCS.L

0.579

BMO Mid Corporate Bond Index ETF

ZCM

0.000

BMO Long Corporate Bond Index ETF

ZLC

0.000

BMO Short-Term US IG Corporate Bond Hedged to CAD Index ETF

ZSU

0.000

BMO Mid-Term US IG Corporate Bond Index ETF

ZIC

0.513

BMO Mid-Term US IG Corporate Bond Index ETF (USD Units)

ZIC.U

0.495

BMO Mid-Term US IG Corporate Bond Hedged to CAD Index ETF

ZMU

0.178

BMO ESG US Corporate Bond Hedged to CAD Index ETF

ESGF

0.000

BMO High Yield US Corporate Bond Hedged to CAD Index ETF

ZHY

0.000

BMO High Yield US Corporate Bond Index ETF

ZJK

0.000

BMO Floating Rate High Yield ETF

ZFH

0.000

BMO Emerging Markets Bond Hedged to CAD Index ETF

ZEF

0.000

BMO Laddered Preferred Share Index ETF

ZPR

0.000

BMO US Preferred Share Index ETF

ZUP

0.000

BMO US Preferred Share Index ETF (USD Units)

ZUP.U

0.000

BMO US Preferred Share Hedged to CAD Index ETF

ZHP

0.000

BMO Conservative ETF

ZCON

0.048

BMO Balanced ETF

ZBAL

0.000

BMO Balanced ESG ETF

ZESG

0.000

BMO Growth ETF

ZGRO

0.000

BMO Monthly Income ETF

ZMI

0.000

BMO Canadian High Dividend Covered Call ETF

ZWC

0.000

BMO Covered Call Canadian Banks ETF

ZWB

0.059

BMO Covered Call US Banks ETF

ZWK

0.000

BMO Covered Call Utilities ETF

ZWU

0.000

BMO Covered Call Dow Jones Industrial Average Hedged to CAD ETF

ZWA

0.999

BMO US High Dividend Covered Call ETF

ZWH

0.000

BMO US High Dividend Covered Call ETF (USD Units)

ZWH.U

0.000

BMO US High Dividend Covered Call Hedged to CAD ETF

ZWS

0.000

BMO Europe High Dividend Covered Call ETF

ZWP

0.000

BMO Europe High Dividend Covered Call Hedged to CAD ETF

ZWE

0.000

BMO Global High Dividend Covered Call ETF

ZWG

0.054

BMO Premium Yield ETF

ZPAY

1.656

BMO Premium Yield ETF (Hedged Units)

ZPAY.F

0.618

BMO Premium Yield ETF (USD Units)

ZPAY.U

1.752

BMO US Put Write ETF

ZPW

0.000

BMO US Put Write ETF (USD Units)

ZPW.U

0.000

BMO US Put Write Hedged to CAD ETF

ZPH

0.000

BMO S&P/TSX Capped Composite Index ETF

ZCN

0.000

BMO MSCI Canada ESG Leaders Index ETF

ESGA

0.057

BMO Canadian Dividend ETF

ZDV

0.000

BMO Low Volatility Canadian Equity ETF

ZLB

0.674

BMO MSCI Canada Value Index ETF

ZVC

0.000

BMO S&P 500 Index ETF

ZSP

0.000

BMO S&P 500 Index ETF (USD Units)

ZSP.U

0.000

BMO S&P 500 Hedged to CAD Index ETF

ZUE

0.000

BMO S&P US Mid Cap Index ETF

ZMID

0.397

BMO S&P US Mid Cap Index ETF (Hedged Units)

ZMID.F

0.038

BMO S&P US Mid Cap Index ETF (USD Units)

ZMID.U

0.741

BMO S&P US Small Cap Index ETF

ZSML

0.245

BMO S&P US Small Cap Index ETF (Hedged Units)

ZSML.F

0.000

BMO S&P US Small Cap Index ETF (USD Units)

ZSML.U

0.419

BMO Dow Jones Industrial Average Hedged to CAD Index ETF

ZDJ

0.140

BMO Nasdaq 100 Equity Index ETF

ZNQ

0.000

BMO Nasdaq 100 Equity Hedged to CAD Index ETF

ZQQ

2.348

BMO MSCI USA ESG Leaders Index ETF

ESGY

0.000

BMO MSCI USA High Quality Index ETF

ZUQ

0.000

BMO MSCI USA High Quality Index ETF (Hedged Units)

ZUQ.F

0.000

BMO MSCI USA High Quality Index ETF (USD Units)

ZUQ.U

0.000

BMO US Dividend ETF

ZDY

0.000

BMO US Dividend ETF (USD Units)

ZUD

0.000

BMO US Dividend Hedged to CAD ETF

ZDY.U

0.000

BMO Low Volatility US Equity ETF

ZLU

0.949

BMO Low Volatility US Equity ETF (USD Units)

ZLH

0.641

BMO Low Volatility US Equity Hedged to CAD ETF

ZLU.U

1.129

BMO MSCI USA Value Index ETF

ZVU

0.000

BMO SIA Focused Canadian Equity Fund – ETF Series

ZFC

0.000

BMO SIA Focused North American Equity Fund – ETF Series

ZFN

0.000

BMO Tactical Dividend ETF Fund – ETF Series

ZZZD

0.000

BMO Women in Leadership Fund – ETF Series

WOMN

0.000

BMO MSCI EAFE Index ETF

ZEA

0.000

BMO MSCI EAFE Hedged to CAD Index ETF

ZDM

0.000

BMO MSCI EAFE ESG Leaders Index ETF

ESGE

0.000

BMO International Dividend ETF

ZDI

0.000

BMO International Dividend Hedged to CAD ETF

ZDH

0.000

BMO Low Volatility International Equity ETF

ZLI

0.000

BMO Low Volatility International Equity Hedged to CAD ETF

ZLD

0.000

BMO MSCI Europe High Quality Hedged to CAD Index ETF

ZEQ

0.000

BMO MSCI EAFE Value Index ETF

ZVI

0.000

BMO MSCI All Country World High Quality Index ETF

ZGQ

0.177

BMO MSCI Global ESG Leaders Index ETF

ESGG

0.000

BMO MSCI Emerging Markets Index ETF

ZEM

0.000

BMO Low Volatility Emerging Markets Equity ETF

ZLE

0.000

BMO China Equity Index ETF

ZCH

0.000

BMO India Equity Index ETF

ZID

1.350

BMO Equal Weight Banks Index ETF

ZEB

0.126

BMO Equal Weight Oil & Gas Index ETF

ZEO

0.000

BMO Equal Weight Utilities Index ETF

ZUT

0.150

BMO Equal Weight REITs Index ETF

ZRE

0.250

BMO Equal Weight Industrials Index ETF

ZIN

0.000

BMO Equal Weight US Health Care Index ETF

ZHU

0.836

BMO Equal Weight US Health Care Hedged to CAD Index ETF

ZUH

3.929

BMO Equal Weight US Banks Index ETF

ZBK

0.000

BMO Equal Weight US Banks Hedged to CAD Index ETF

ZUB

0.000

BMO Global Infrastructure Index ETF

ZGI

0.917

BMO Equal Weight Global Base Metals Hedged to CAD Index ETF

ZMT

0.000

BMO Equal Weight Global Gold Index ETF

ZGD

7.000

BMO Global Consumer Discretionary Hedged to CAD Index ETF

DISC

0.089

BMO Global Consumer Staples Hedged to CAD Index ETF

STPL

0.000

BMO Global Communications Index ETF

COMM

0.292

BMO Junior Gold Index ETF

ZJG

0.000

BMO Junior Oil Index ETF

ZJO

0.000

BMO Junior Gas Index ETF

ZJN

0.000


1 BMO ETFs are managed by BMO Asset Management Inc., which is an investment fund manager and a portfolio manager, and a separate legal entity from Bank of Montreal. ETF Series of the BMO Mutual Funds are managed by BMO Investments Inc., which is an investment fund manager and a separate legal entity from Bank of Montreal.


2 Forward-looking information: This notice contains forward-looking statements with respect to the estimated annual distributions for the ETFs. By their nature, these forward-looking statements involve risks and uncertainties that could cause the actual distributions to differ materially from those contemplated by the forward-looking statements. Material factors that could cause the actual distributions to differ from the estimated distributions include, but are not limited to: the actual amounts of distributions received by the ETFs; portfolio transactions; and subscription and redemption activity.

The Dow Jones Industrial Average Index CAD Hedged is a product of Dow Jones Opco, LLC (“Dow Jones Opco”), a subsidiary of S&P Dow Jones Indices LLC, and has been licensed for use. “Dow Jones®” and “Industrial Average Index CAD Hedged” are service marks of Dow Jones Trademark Holdings, LLC (“Dow Jones”), and have been licensed to Dow Jones Opco and sublicensed by BMO Asset Management Inc. in connection with ZWA and ZDJ. ZWA and ZDJ are not sponsored, endorsed, sold or promoted by Dow Jones Opco, Dow Jones and their respective affiliates, and they make no representation regarding the advisability of trading or investing in ZWA and ZDJ.

S&P®, S&P/TSX Capped Composite®, S&P 500® are trademarks of Standard & Poor’s Financial Services LLC (“S&P”). “TSX” is a trademark of TSX Inc. These trademarks have been licensed for use by S&P Dow Jones Indices LLC and sublicensed to BMO Asset Management Inc. in connection with ZCN, ZUE, ZSP, ZSP.U, ZMID, ZMID.F, ZMID.U, ZSML, ZSML.F, and ZSML.U. These BMO ETFs are not sponsored, endorsed, sold or promoted by S&P Dow Jones LLC, S&P, TSX, or their respective affiliates and S&P Dow Jones Indices LLC, S&P, TSX and their affiliates make no representation regarding the advisability of trading or investing in such BMO ETFs.

NASDAQ®, and NASDAQ-100 Index® Hedged to CAD and BMO NASDAQ 100 Equity Index ETF, are registered trademarks of Nasdaq, Inc. (which with its affiliates is referred to as the “Corporations”) and are licensed for use by BMO Asset Management Inc. BMO Nasdaq 100 Equity Hedged to CAD Index ETF has not been passed on by the Corporations as to their legality or suitability and is not issued, endorsed, sold, or promoted by the Corporations. THE CORPORATIONS MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO the BMO Nasdaq 100 Equity Hedged to CAD Index ETF and BMO NASDAQ 100 Equity Index ETF.

The BMO ETFs or securities referred to herein are not sponsored, endorsed or promoted by MSCI Inc. (“MSCI”), and MSCI bears no liability with respect to any such BMO ETFs or securities or any index on which such BMO ETFs or securities are based. The prospectus of the BMO ETFs contains a more detailed description of the limited relationship MSCI has with BMO Asset Management Inc. and any related BMO ETFs.

®/™Registered trademarks/trademark of Bank of Montreal, used under licence.

BMO Global Asset Management is a brand name that comprises BMO Asset Management Inc., BMO Investments Inc., BMO Asset Management Corp., BMO Asset Management Limited and BMO’s specialized investment management firms.

BMO ETFs are managed by BMO Asset Management Inc., which is an investment fund manager and a portfolio manager, and a separate legal entity from Bank of Montreal. ETF Series of the BMO Mutual Funds are managed by BMO Investments Inc., which is an investment fund manager and a separate legal entity from Bank of Montreal.

Commissions, management fees and expenses (if applicable) all may be associated with investments in BMO ETFs and ETF Series of the BMO Mutual Funds.  Please read the ETF Facts or prospectus of the relevant BMO ETF or ETF Series before investing.  BMO ETFs and ETF Series are not guaranteed, their values change frequently and past performance may not be repeated.

For a summary of the risks of an investment in the BMO ETFs or ETF Series of the BMO Mutual Funds, please see the specific risks set out in the prospectus.  BMO ETFs and ETF Series trade like stocks, fluctuate in market value and may trade at a discount to their net asset value, which may increase the risk of loss. Distributions are not guaranteed and are subject to change and/or elimination.

About BMO Exchange Traded Funds (ETFs)
BMO Exchange Traded Funds has been a leading ETF provider in Canada for 11 years, with 96 mandates and 30 per cent market share in Canada. BMO ETFs are designed to stay ahead of market trends and provide compelling solutions to help advisors and investors. This includes a comprehensive suite of ETFs developed in Canada for Canadians, such as cost effective core equity ETFs following market leading indexes, and a broad range of fixed income ETFs; solution-based ETFs responding to client demand; and innovation with smart beta ETFs, as well as combining active and passive investing with ETF series of award-winning active mutual funds.

About BMO Financial Group 
Serving customers for 200 years and counting, BMO is a highly diversified financial services provider – the 8th largest bank, by assets, in North America. With total assets of $974 billion as of July 31, 2020, and a team of diverse and highly engaged employees, BMO provides a broad range of personal and commercial banking, wealth management and investment banking products and services to more than 12 million customers and conducts business through three operating groups: Personal and Commercial Banking, BMO Wealth Management and BMO Capital Markets.

SOURCE BMO Financial Group

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of HD Supply Holdings, Inc. Buyout

WILMINGTON, Del., Nov. 16, 2020 (GLOBE NEWSWIRE) — Rigrodsky & Long, P.A. announces that it is investigating HD Supply Holdings, Inc. (“HD Supply”) (NASDAQ GS: HDS) regarding possible breaches of fiduciary duties and other violations of law related to HD Supply’s agreement to be acquired by The Home Depot, Inc. (“Home Depot”) (NYSE: HD). Under the terms of the agreement, HP Supply’s shareholders will receive $56.00 in cash per share.

To learn more about this investigation and your rights, visit: https://www.rl-legal.com/cases-hd-supply-holdings-inc.

You may also contact Seth D. Rigrodsky or Gina M. Serra cost and obligation free at (888) 969-4242 or [email protected].

Rigrodsky & Long, P.A., with offices in Delaware and New York, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in securities fraud and corporate class actions nationwide.

Attorney advertising.  Prior results do not guarantee a similar outcome.

CONTACT:         

Rigrodsky & Long, P.A.
Seth D. Rigrodsky
Gina M. Serra
(888) 969-4242 (Toll Free)
(302) 295-5310
Fax: (302) 654-7530
[email protected]
https://rl-legal.com



Eclipse Senior Living Launches Empower Hour Webcast Aimed at Helping Family Caregivers Navigate Uncertain Times

The new series reinforces the senior living brand’s commitment to cultivating healthy, happy communities

LAKE OSWEGO, Ore., Nov. 16, 2020 (GLOBE NEWSWIRE) — Eclipse Senior Living, a national manager of distinctive Independent, Assisted Living and Memory Care communities across the United States, today announced the launch of Empower Hour, a new webcast series dedicated to supporting family caregivers as they navigate the uncertainties and challenges of life while caring for an aging loved one. The series premiere, “5+ Things to Know When Caring for an Aging Loved One During the Holidays,” will webcast on Wednesday, November 18 at 12 p.m. PT / 3 p.m. ET. A recording of the webcast will be available following the live event.

Empower Hour comes at a time when more people than ever are taking on the role of family caregiver. According to data from the National Alliance for Caregiving and AARP, roughly 34.2 million Americans had provided unpaid care to an adult age 50 or older in the last 12 months.1 And all of those hours of unpaid care add up — on average, caregivers spend 13 days per month on household tasks, 6 days per month assisting with personal tasks and 13 hours per month researching diseases and coordinating medical visits.2

“Holidays present unique challenges for family caregivers, and those challenges are amplified this year due to the ongoing COVID-19 pandemic,” said Sharon Roth Maguire, Eclipse Senior Living’s senior vice president of wellness, care and quality. “We’re thrilled to be kicking off Empower Hour with an impactful examination of one of the most challenging times of the year for caregivers.”

Participants who tune into the premiere Empower Hour webcast have the opportunity to
hear from Eclipse’s national experts on geriatric care and dementia, and learn more about important topics related to family caregiving, including:

  • The changing perceptions and expectations of family caregiving today
  • Understanding the dynamics of family relationships and caring for aging parents
  • Tips for creating low-stress, meaningful holidays with aging loved ones
  • The causes of anxiety within families during the holiday season
  • Knowing when a higher level of help is needed as well as the available options

To learn more about Empower Hour and to register for the webcast, visit: www.elmcroft.com/empower.

About Eclipse Senior Living

Eclipse Senior Living is a national manager of distinctive Independent, Assisted Living and Memory Care communities across the United States, including the brands Elmcroft™ and Embark™. The Eclipse Senior Living portfolio includes over 100 communities in more than 25 states. To learn more about Eclipse Senior Living, visit: https://www.eclipseseniorliving.com/.

1 National Alliance for Caregiving and AARP (2015)
2 Gallup-Healthways Well-Being Index (2011)



Contact: 
Jamison Gosselin
[email protected]

Professional Community Management Names Matthew Williams as Branch President

Foothill Ranch, CA, Nov. 16, 2020 (GLOBE NEWSWIRE) — Professional Community Management (PCM), an Associa® company, recently named Matthew Williams, CMCA®, AMS®, PCAM®, as the new branch president. 

With more than 14 years of community management experience, including four years at Associa Colorado, first as vice president and most recently as branch president, Matt has demonstrated an ability to work throughout all levels of the business to establish positive relationships with community leaders, clients, and colleagues. His achievements and ability underscore his approach to helping team members grow and succeed, while taking on new responsibilities and continuing his own development.  As a collaborative team player, Matt brings a balance of communication, relationship, analytical and problem-solving skills to his role as PCM’s new president. 

In addition to his professional experience, Mr. Williams brings with him a commitment to giving back to the industry as a volunteer. He served as a delegate on the Community Associations Institute’s (CAI) Colorado Legislative Action Committee (CLAC), where he also helped educate state legislators, providing invaluable advice when community association issues arose.  

“Matt has been a valued member of the Associa family since joining the team, and his industry knowledge, leadership abilities, resourcefulness, and drive make him ideal for this next challenge,” stated Ann Williams, Associa regional vice president. “Matt has an essential understanding of the importance of developing client relationships built on collaboration and communication, and we are excited to have him leading the PCM branch.” 

Mr. Williams earned his Bachelor of Science degree in Business Administration from the University of Wyoming in Laramie. He also holds the Certified Manager of Community Associations (CMCA®) designation from the Community Association Managers International Certification Board (CAMICB) and the Association Management Specialist (AMS®) and Professional Community Association Manager (PCAM®) designations from the Community Associations Institute (CAI). 

With more than 200 branch offices across North America, Associa delivers unsurpassed management and lifestyle services to nearly five million residents worldwide. Our 10,000+ team members lead the industry with unrivaled education, expertise and trailblazing innovation. For more than 40 years, Associa has provided solutions designed to help communities achieve their vision. To learn more, visit www.associaonline.com.

Stay Connected: 

Like us on Facebook: https://www.facebook.com/associa

Subscribe to the Blog: https://hub.associaonline.com/

Follow us on Twitter: https://twitter.com/associa

Join us on LinkedIn: http://www.linkedin.com/company/associa



Ashley Cantwell
Associa 
214-272-4107
[email protected]

CargoAir Switches to AEI for Two (2) AEI B737-800SF Freighter Conversions

MIAMI, Nov. 16, 2020 (GLOBE NEWSWIRE) — Aeronautical Engineers, Inc. (AEI) today announced the company has signed a contract to provide Bulgaria-based CargoAir with two AEI B737-800SF Freighter Conversions. CargoAir originally signed agreements for two B737-800BCF conversions, however, the company recently cancelled those agreements and signed up with AEI – citing AEI’s responsiveness, slot flexibility, ease of doing business, and the intrinsic value the AEI B737-800SF provides as a better-priced option. This past year AEI added two additional authorized AEI Conversion Centers and currently has slots available starting in May 2021.

“CargoAir is a highly valued customer, which currently operates three AEI B737-300SF and seven AEI B737-400SF freighters. At present, we are converting a B737-400SF for CargoAir, which will be redelivered in January 2021,” stated Robert T. Convey, AEI Senior Vice President Sales & Marketing. “We are proud that CargoAir continues to recognize the extraordinary business value of all our freighter conversion products, including the B737-800SF, and we are delighted that our renowned accommodative business approach and responsive customer service has again been affirmed with this recent order.”

CargoAir’s recently acquired B737-800 aircraft (MSN 30664) is scheduled to commence modification in January 2021. All modification touch labor will be performed by the authorized AEI Conversion Center, Commercial Jet, in Dothan, Alabama.

CargoAir will benefit from AEI’s B737-800SF main deck payload of up to 52,700 lbs. (23,904 kg) and its eleven full height 88” x 125” container positions, plus an additional position for an AEP/AEH. The conversion also incorporates new floor beams aft of the wing box, a large 86” x 137” Main Cargo Door with a single vent door system, and a flexible Ancra Cargo Loading System. The AEI B737-800SF also includes a rigid 9g barrier, five supernumerary seats as standard, a galley and full lavatory.

When combined with proven reliability, ruggedness, and low cost, the AEI Converted B737-800SF will allow CargoAir to keep their aircraft – “In the air, generating revenue”.

A
bout AEI

Aeronautical Engineers, Inc. (AEI) is a global leader in the aircraft passenger-to-freighter conversion business and is the oldest conversion company in existence today. Since the company’s founding in 1958, AEI has developed over 130 Supplemental Type Certificates (STCs) and has modified over 510 aircraft with the STCs. AEI helps its customers extend aircraft life and increase the overall value of aircraft assets by continuously focusing on dependable and flexible product offerings. AEI currently offers passenger-to-freighter conversions for the Boeing 737-800, 737-400, 737-300, MD-80 series, and CRJ200 aircraft. www.aeronautical-engineers.com

About CargoAir

CargoAir is a Sofia, Bulgaria-based cargo airline. The company was founded in 1997, initially operating six AN-12 aircraft. CargoAir currently operates a fleet of three B737-300 and seven B737-400 freighters. CargoAir has established long-term operations for Integrated Express and Mail operators such as DHL and UPS and has contracted its freighter fleet to support their specific network requirements. The company is also dedicated to ad hoc cargo charter flights worldwide, providing customer-oriented solutions for cargo brokers, freighter forwarders and logistics companies requiring the transportation of dangerous goods, special cargo, and outsized loads. www.cargoair.bg.

AEI Contact:

Robert T. Convey
Senior Vice President Sales & Marketing
+1 (818) 406-3666
[email protected]



GitLab Appoints Chief People Officer and Newest Board Member

SAN FRANCISCO, Nov. 16, 2020 (GLOBE NEWSWIRE) — GitLab, the DevOps platform delivered as a single application, announced today the appointment of Wendy Nice Barnes as Chief People Officer (CPO) and Merline Saintil to its board of directors. Both additions bring extensive experience to the company and will help GitLab further its position as a leading DevOps platform.

“As GitLab continues to grow, it is vital to our success to bring onboard key individuals who will help us maintain high growth and market leadership,” said Sid Sijbrandij, co-founder and CEO of GitLab. “Wendy has an impressive history of mentoring colleagues and growing leaders from within organizations. While Merline’s global award-winning product creation has enabled Fortune 500 companies to manage cyber risk at scale. Both embody our CREDIT values and are tremendous additions to the company.”

Barnes joins GitLab with over 20 years of Talent leadership experience in pre-IPO and Fortune 500 companies. She served as Chief Human Resources Officer at Palo Alto Networks, Vice President of Human Resources at eHealth, and held senior HR leadership roles at Netflix and E*TRADE.

“GitLab is not only a shining example of how to run a successful all remote company, but they are consistently recognized as a top company to work for,” said Barnes. “I am looking forward to joining such a transparent group of people, leading with the members of the executive team and working closely with its DIB (Diversity, Inclusion and Belonging) and remote leaders to further the great foundation set forth.”

Saintil currently serves on the boards of Lightspeed, Alkami Technology, Banner Corporation, and ShotSpotter and was recognized as one of the Most Influential Corporate Board Directors by Women Inc. She is a member of the National Association of Corporate Directors (NACD) and is certified in Cybersecurity Oversight by NACD and the Carnegie Mellon Software Engineering Institute. Saintil previously held leadership roles with iconic Fortune 500 and privately held companies including Intuit, Yahoo!, PayPal, Adobe, Joyent and Sun Microsystems. She has also received a Lifetime Achievement Award by Girls in Tech.

“GitLab has enabled its enterprise customers to shift left by seamlessly incorporating security into its single DevOps platform making them a unique company to watch,” said Saintil. “I’m honored to join its board of directors and have the opportunity to bring my engineering, enterprise risk and cybersecurity experience to support the company as it grows its footprint globally.”

GitLab Velocity and Recognition

The company has experienced 50x growth in 4 years and surpassed $150M in annual recurring revenue earlier this year with more than 30M estimated registered users.

GitLab recently ranked 13 on the Forbes’ 2020 Cloud 100 List (up from 32nd place in 2019) and was listed on the Enterprise Tech 30 2020 as a late-stage private company. GitLab also earned the ranking of no. 268 on the 2020 Inc. 5000 list of the fastest-growing private companies in America.


Workplace Recognition

GitLab placed 35th on Forbes’ 2020 list of America’s Best Startups for Employers and made the Inc.’s Best Workplaces of 2020 (for the second year in a row). The company was named a finalist in the Workplace category in Fast Company’s 2020 Innovation by Design Awards, listed as a top employer in Hired’s Brand Health Report, is among Fortune’s 100 Best Small & Medium Workplaces in 2020, and was named “2020 Best Company to Work for” by the Product Marketing Alliance. 2020 Working Mother Media listed GitLab among the 100 Best Companies for successfully helping employees integrate home and work life.


Product Recognition

GitLab 13.0 recently won 2020 CRN Tech Innovator Awards in the IT/Application Automation category. The company was also recognized as a “451 Firestarter” by 451 Research and was awarded the DevOps Dozen award for Best DevOps Solution Provider by industry leaders MediaOps and DevOps.com, Forrester named the company a 2020 Strong Performer for Continuous Delivery and Release Automation and Gartner cited GitLab as a Visionary in its Enterprise Agile Planning Tools Magic Quadrant and named the company a 2020 Customers’ Choice for Application Release Orchestration in its Peer Insights “Voice of the Customer” review.

About GitLab

GitLab is a DevOps platform built from the ground up as a single application for all stages of the DevOps lifecycle enabling Product, Development, QA, Security, and Operations teams to work concurrently on the same project. GitLab provides a single data store, one user interface, and one permission model across the DevOps lifecycle. This allows teams to significantly reduce cycle times through more efficient collaboration and enhanced focus.

Built on Open Source, GitLab works alongside its growing community, which is composed of thousands of developers and millions of users, to continuously deliver new DevOps innovations. More than 100,000 organizations from startups to global enterprises, including Ticketmaster, Jaguar Land Rover, NASDAQ, Dish Network, and Comcast trust GitLab to deliver great software faster. All-remote since 2014, GitLab has more than 1,300 team members in 68 countries.

Media Contact

Natasha Woods

GitLab

[email protected]



Robert Barnhill, Jr. Reminds Shareholders of Their Right to Remove TESSCO Directors Hastily Appointed Last Week Without Shareholder Approval

Submitting a WHITE Consent Card FOR the Removal of Any of John D. Beletic, Jay G. Baitler, Paul J. Gaffney, Morton F. Zifferer, Jr. or Dennis J. Shaughnessy Constitutes a Consent to Remove Cathy-Ann Martine-Dolecki, Ronald D. McCray and Any Other Directors Appointed to the Board Prior to the Conclusion of the Consent Solicitation

Consent to the Election of Robert Barnhill Jr.’s Highly-Qualified Independent Candidates to the TESSCO Board

PR Newswire

HUNT VALLEY, Md., Nov. 16, 2020 /PRNewswire/ — On November 16, 2020, Robert B. Barnhill, Jr., founder and largest shareholder of TESSCO Technologies, Incorporated (NASDAQ: TESS) (“TESSCO” or the “Company”), issued the following press release in response to the dubiously-timed additions to the Company’s Board of Directors (the “Board”):

Last week, the Board took what Mr. Barnhill deems an extraordinarily reactionary and defensive tactic to further entrench the majority influence held by incumbent directors, John D, Beletic, Jay G. Baitler and Paul J. Gaffney over a captive Board. We believe that the recent addition of two new directors to the Board without shareholder approval (“Unilateral Board Appointments”) in the middle of a consent solicitation process is rash and reactionary and a failure of good corporate governance. In our view, a slight Board compositional change effected without shareholder approval is not sufficient to remedy the enormous issues facing the Company. Based on the Company’s annual meeting results from 2019 and 2020, we believe it is clear the Board lacked a mandate from shareholders to undertake this exercise, particularly on the eve of its meetings with proxy advisory firms and institutional shareholders. 

Fortunately, Mr. Barnhill’s definitive consent solicitation statement (the “Solicitation Statement”) and accompanying WHITE consent card contemplated the possibility of the Unilateral Board Appointments.

  • Proposal 1 in the Solicitation Statement and WHITEconsent card provides that a consent for the removal of any of John D. Beletic, Jay G. Baitler, Paul J. Gaffney, Morton F. Zifferer, Jr. or Dennis J. Shaughnessy (collectively, the “Subject Directors”) also constitutes a consent to remove any other person(s) elected, appointed or designated by the Board (or any committee thereof) to fill any vacancy or newly created directorship on or after September 25, 2020 and prior to the conclusion of Mr. Barnhill’s consent solicitation (the “Consent Solicitation”); 
  • Consequently, this means that consenting to remove any director named in Proposal 1 on the WHITE consent card also constitutes a consent to remove the two directors recently added as a result of the Unilateral Board Appointments (Cathy-Ann Martine-Dolecki and Ronald D. McCray); and
  • This also means that consenting to remove any director named in Proposal 1 on the WHITE consent card constitutes a consent to remove any additional non-shareholder approved director elected, appointed or designated by the Board during the remainder of the Consent Solicitation.

As a result, removal of any Subject Director1 by the affirmative consent of holders of a majority of shares of the Company’s common stock (“Common Stock”) as of the October 13, 2020 record date will result in the removal of all directors appointed or designated by the Board on or after September 25, 2020 and prior to the completion of the Consent Solicitation, including Ms. Martine-Dolecki and Mr. McCray. 

We believe the Unilateral Board Appointments to be a direct entrenchment tactic and a blatant attempt to confuse shareholders during the Consent Solicitation. We do not believe that the Subject Directors, who have lost shareholder support, should be able to frustrate the will of the shareholders by unilaterally appointing new directors without shareholder approval during a consent solicitation. However, consistent with shareholders’ best interest, following the Consent Solicitation, Mr. Barnhill plans to recommend to the reconstituted Board that it interview Ms. Martine-Dolecki and Mr. McCray for possible directorships, while also taking shareholder feedback into account.

At your earliest convenience, please consent to remove the Subject Directors (which will also result in the removal of Ms. Martine-Dolecki and Mr. McCray, the two directors recently appointed as a result of the Unilateral Board Appointments), and replace them with our four highly-qualified independent candidates—J. Timothy Bryan, John W. Diercksen, Emily Kellum (Kelly) Boss and Kathleen McLean.

TAKE ACTION TODAY!

Consent and Consent Revocation Procedures

We urge you to consent to all four proposals on the WHITE consent card and return it in your postage-paid envelope provided prior to December 11, 2020. An executed consent card may be revoked at any time by marking, dating, signing and delivering a written revocation before the time that the action authorized by the executed consent becomes effective. A revocation may be in any written form validly signed by the record holder as long as it clearly states that the consent previously given is no longer effective. The delivery of a subsequently dated consent card that is properly completed will constitute a revocation of any earlier consent. The revocation may be delivered to Harkins Kovler, LLC at the address set forth below.
If you hold your share in “street” name with a brokerage firm, bank, dealer, trust company or other nominee, please consult such nominee for instructions on how to consent or revoke your consent.

If you have any questions about the Consent Solicitation or need assistance executing the WHITE consent card, please contact:


Harkins Kovler, LLC

3 Columbus Circle, 15th Floor


New York, NY 10019

Telephone: +1 (212) 468-5380

Toll-Free: +1 (800) 257-3995

Email: [email protected]

Important Additional Information

Mr. Barnhill, Ms. McLean, Ms. Boss, Mr. Bryan, Mr. Diercksen, UA 6-9-2016Robert B. Barnhill, Jr. Rev Trust, RBB-TRB LLC, a Maryland limited liability company (“RBB-TRB”), RBB-CRB LLC, a Maryland limited liability company (“RBB-CRB”), Robert B Barnhill Jr & Janet W Barnhill Tr FBO Durkin Slattery Barnhill Trust, Janet W Barnhill Tr UA 6 9 2016 Janet W Barnhill Rev Trust, Winston Foundation, Incorporated, a Maryland corporation, and Donald Manley (the “Participants” or “We”) are participants in the solicitation of consents from the Company’s shareholders to remove the Subject Directors (and any other person or persons, other than those elected by the Consent Solicitation, elected, appointed or designated by the Board (or any committee thereof) to fill any vacancy or newly created directorship on or after September 25, 2020 and prior to the time that any of the actions proposed to be taken by the Consent Solicitation become effective) and elect Ms. McLean, Ms. Boss, Mr. Bryan and Mr. Diercksen to fill four of the resulting vacancies (as well as to amend the Company’s Sixth Amended and Restated By-Laws proposed in connection therewith). We have filed the Solicitation Statement and a WHITE consent card with the Securities and Exchange Commission (the “SEC”) in connection with any such solicitation of proxies from the Company’s shareholders.

SHAREHOLDERS OF THE COMPANY ARE STRONGLY ENCOURAGED TO READ THE SOLICITATION STATEMENT, ACCOMPANYING WHITE CONSENT CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY AS THEY CONTAIN IMPORTANT INFORMATION. UPDATED INFORMATION REGARDING THE IDENTITY OF POTENTIAL PARTICIPANTS AND THEIR DIRECT OR INDIRECT INTERESTS, BY SECURITY HOLDINGS OR OTHERWISE, IS SET FORTH IN THE SOLICITATION STATEMENT AND OTHER MATERIALS FILED WITH THE SEC. Shareholders can obtain the Solicitation Statement and any amendments or supplements to the Solicitation Statement filed by the Participants with the SEC at no charge at the SEC’s website at www.sec.gov. Copies will also be available, without charge, on request from the Participants’ proxy solicitor, Harkins Kovler, LLC at +1 (800) 257-3995 or via email at [email protected].

Certain Information Regarding the Participants

Mr. Barnhill is the founder, former Chairman of the Board and the largest shareholder of the Company.

Mr. Barnhill beneficially owns 1,620,387 shares of the Common Stock (approximately 18.5% of the outstanding shares), which includes 11,503.5 shares that Mr. Barnhill owns directly and the shares owned by the following Participants: UA 6-9-2016Robert B. Barnhill, Jr. Rev Trust owns 1,265,882 shares of Common Stock, RBB-TRB, LLC owns 109,125 shares of Common Stock, RBB-CRB, LLC owns 109,125 shares of Common Stock, Robert B Barnhill Jr & Janet W Barnhill Tr FBO Durkin Slattery Barnhill Trust, owns 30,750 shares of Common Stock, Janet W Barnhill Tr UA 6 9 2016 Janet W Barnhill Rev Trust owns 67,500 shares of Common Stock, and the Winston Foundation, Incorporated owns 26,500 shares of Common Stock. Mr. Barnhill is the sole manager of RBB-TRB and RBB-CRB, a trustee of the UA 6-9-2016Robert B. Barnhill, Jr. Rev Trust and the Robert B Barnhill Jr & Janet W Barnhill Tr FBO Durkin Slattery Barnhill Trust and a director of the Winston Foundation, Incorporated. Mr. Barnhill’s spouse is a trustee of the Janet W Barnhill Tr UA 6 9 2016 Janet W Barnhill Rev Trust. The percentage of Mr. Barnhill’s stock ownership is based on the 8,760,562 shares of Common Stock outstanding as of October 13, 2020, as reported in the Company’s Consent Revocation Statement on Schedule 14A, filed with the SEC on October 15, 2020. Christopher Barnhill may be considered a Participant in the solicitation but is no longer providing any assistance with respect to the solicitation and does not currently beneficially, directly or indirectly own any securities of the Company.

None of the Participants (other than Mr. Barnhill) currently beneficially, directly or indirectly own any securities of the Company.

Investor/Media Contacts:

Harkins Kovler, LLC
Peter Harkins, Jr. / Rahsaan Wareham
(212) 468-5394 / (212) 468-5399
[email protected] / [email protected]


1 Mr. Shaughnessy was originally a Subject Director targeted for removal by the Consent Solicitation. However, he retired in connection with the Unilateral Board Appointments. Therefore, shareholder approval of the removal of Mr. Shaughnessy will only have the effect of removing all directors appointed or designated by the Board on or after September 25, 2020 and prior to the completion of the Consent Solicitation.

 

Cision View original content:http://www.prnewswire.com/news-releases/robert-barnhill-jr-reminds-shareholders-of-their-right-to-remove-tessco-directors-hastily-appointed-last-week-without-shareholder-approval-301173916.html

SOURCE Mr. Robert B. Barnhill, Jr.

SINTX Technologies Shares Q3 Business Update and Identifies Growth Opportunities for 2021

SALT LAKE CITY, Nov. 16, 2020 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (www.sintx.com) (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of silicon nitride ceramic for medical and non-medical applications, shared details on its Q3 business update and new business opportunities ahead.

Throughout the pandemic, SINTX has continued to address the impact of COVID-19 on its business operations. The Company has avoided layoffs and invested in the safety of its employees through new protocols and work from home policies. As such, SINTX has been able to maintain business operations as usual in Q3, except for the reduction in spine sales which we discuss below.

“Despite an unpredictable year, we feel fortunate that our business has been able to minimize the impact of COVID-19,” said Dr. Sonny Bal, President, and CEO, SINTX Technologies. “Our business has been able to hire new employees, expand necessary research and development, and engage with new customers to create a variety of applications using our silicon nitride. As one example, we manufactured and shipped industrial prototype parts for the first time in our history. We’re looking forward to additional growth in 2021 and aggressively pursuing the opportunities in front of us.”

Third Quarter Financial Results

SINTX reported revenue of $0.1 million for the three months ended September 30, 2020, and $0.5 million for the nine months ended September 30, 2020. Generally accepted accounting principles (GAAP) basic net loss for the three months ended September 30, 2020, was $0.11 per share, compared to a basic net loss of $0.68 per share for the three months ended September 30, 2019. For the nine months ended September 30, 2020, the Company reported a GAAP basic net loss of $0.39 per share, compared to a basic net loss of $3.00 per share for the nine months ended September 30, 2019. The Company’s cash and cash equivalents were $27.1 million as of September 30, 2020, an increase of $25.3 million from December 31, 2019.

The Company shipped one aerospace prototype order in the quarter. The balance of the revenue came from sales of production and prototype components to CTL Amedica.

SINTX reported a significant reduction in the number of remaining unconverted preferred shares from the May 2018 and February 2020 offerings as well as in the number of unexchanged warrants. The details can be found in the 10-Q.

Medical Devices Update

Overall, revenue from medical devices was predictably down due to hospital restrictions on elective surgeries taking place during the COVID-19 pandemic. Those restrictions are expected to continue to hurt US sales to CTL Amedica of the Valeo product line. However, CTL Amedica has gained regulatory clearance in Taiwan and future sales to CTL Amedica are anticipated in support of the expected growth from that new opportunity. Furthermore, SINTX and CTL Amedica have been collaborating on the development of new spinal implants made from monolithic silicon nitride and SINTX’s Silicon Nitride-PEEK composite, and sales from those products are expected in 2021.

The COVID-19 pandemic has also impacted SINTX’s collaborative efforts in the dental market. However, SINTX’s partners have recently renewed contact and those projects are moving forward. These projects are looking both at monolithic silicon nitride implants as well as coatings of silicon nitride on titanium implants. Revenue from these opportunities is not expected for several years as silicon nitride is a novel material in dental applications, and would have a lengthy regulatory pathway to navigate.

SINTX has previously referenced a Material Transfer Agreement with a global medical device manufacturer and this project is also still active. Progress has been impacted by the COVID-19 pandemic as well as by the Company’s emphasis on research and development of novel antipathogenic applications for the Company’s silicon nitride.

SINTX added a new U.S. Patent for antibacterial applications of silicon nitride to its technology IP portfolio in Q3. The issued US Patent 10,806,831 broadly covers a variety of biomedical implants wherein the Company’s silicon nitride is applied to improve the antibacterial characteristics of the implant. The first composite product protected under this patent has already been developed and is expected to be commercialized in 2021.

The Company believes there are significant future revenue-generating opportunities in the medical device market. In support of that belief, Michael Marcroft was recently hired as a Vice President of Business Development to identify and grow new opportunities in this market. Silicon nitride’s twelve years of successful outcomes in spinal fusion surgery provide a solid foundation for new medical device applications.

Non-Medical Product Opportunities Ahead

SINTX has experienced growth of customer interest in antipathogenic silicon nitride applications. The Company is in active product development discussions with automotive, IT device, face mask, and air filter manufacturers. SINTX’s partnership with O2TODAY to develop a “catch-and-kill” mask that will inactivate respiratory viruses and bacteria continues to progress and is in the manufacturing process development stage. SINTX continues to prioritize the product development of antipathogenic applications through workforce expansion, acquisition of prototype manufacturing and supporting laboratory equipment, and the development of test protocols to assess the antipathogenic properties of new products.

SINTX has gained the ability to enter the aerospace and defense markets through its recently announced AS9100D certification, which enables SINTX to supply components directly to these industries. The certification means that SINTX now meets the highly stringent standards of these industries and is listed in the OASIS database, used by aerospace suppliers like Boeing, Lockheed Martin, Raytheon, United Technologies, North Grumman, and the United States military. The Company has received orders for and shipped prototype components to companies in this industry.

With new partnership opportunities in place and a shift in business focus toward antipathogenic applications, SINTX has decided not to pursue its previously-announced relationship with Nissin.

Research & Development Updates

In prior years, SINTX made a substantial investment to confirm and understand the osteogenic and antipathogenic properties of the Company’s silicon nitride. The Company has now pivoted towards an R&D investment strategy that is focused on developing products for new markets that leverage these properties.

Where appropriate, SINTX has sought additional funding through highly-competitive external grant opportunities. Although no awards have been received to-date, SINTX’s solid financial condition means that this has not impacted the pace of its research and development activities.

“Our focus going into 2021 is to develop and commercialize silicon nitride-embedded fabrics for a variety of applications,” said Dr. Bal. “Another focus is the commercialization of our polymer-silicon nitride composite technology. The third area of focus is the development of silicon nitride coatings on titanium. All of these areas of focus target multiple opportunities in the medical as well as the non-medical markets. In addition, we are aggressively targeting the industrial markets for silicon nitride, including selected strategic opportunities in that space. We are well-capitalized to make the necessary investments in personnel and equipment to generate new revenues.”

About SINTX Technologies, Inc.

SINTX Technologies is an OEM ceramics company that develops and commercializes silicon nitride for medical and non-medical applications. The core strength of SINTX Technologies is the manufacturing, research, and development of silicon nitride ceramics for external partners. The Company presently manufactures silicon nitride powders and components in its FDA registered, ISO 9001:2015 certified, ISO 13485:2016 certified, and AS9100D certified manufacturing facility.

For more information on SINTX Technologies or its silicon nitride material platform, please visit www.sintx.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA) that are subject to a number of risks and uncertainties. Risks and uncertainties that may cause such differences include, among other things: incorporation of silicon nitride into personal protective equipment may not be safe or effective; volatility in the price of SINTX’s common stock; the uncertainties inherent in new product development, including the cost and time required to commercialize such product(s); market acceptance of our products once commercialized; SINTX’s ability to raise additional funding and other competitive developments. Readers are cautioned not to place undue reliance on the forward-looking statements, which speak only as of the date on which they are made and reflect management’s current estimates, projections, expectations and beliefs. There can be no assurance that any of the anticipated results will occur on a timely basis or at all due to certain risks and uncertainties, a discussion of which can be found in SINTX’s Risk Factors disclosure in its Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on March 26, 2020, and in SINTX’s other filings with the SEC. SINTX disclaims any obligation to update any forward-looking statements. SINTX undertakes no obligation to publicly revise or update the forward-looking statements to reflect events or circumstances that arise after the date of this report.

Business Inquiries for SINTX:

SINTX Technologies
801.839.3502
[email protected]

Media Inquiries for SINTX:

Amanda Barry
Associate Director, Content and PR
The Summit Group
[email protected]